Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-019311

Options or other derivatives

  • Director acquired 22,058 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sabbagh Marwan · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-14 Grant or award : show line 1 in the form Stock Option (right to buy) +22,058 22,058 D
Loading xslF345X03/doc4.xml…